These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 21880452

  • 21. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch, Prasad ChS, Bharathi DV, Shankar R, Rao VJ, Dandala R, Naidu A.
    J Pharm Biomed Anal; 2007 Jan 17; 43(2):733-40. PubMed ID: 16950586
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Determination and characterization of degradation products of anastrozole by LC-MS/MS and NMR spectroscopy.
    Sitaram C, Rupakula R, Reddy BN.
    J Pharm Biomed Anal; 2011 Dec 15; 56(5):962-8. PubMed ID: 21890298
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Identification of novel rapamycin derivatives as low-level impurities in active pharmaceutical ingredients.
    Zech SG, Carr M, Mohemmad QK, Narasimhan NI, Murray C, Rozamus LW, Dalgarno DC.
    J Antibiot (Tokyo); 2011 Sep 15; 64(9):649-54. PubMed ID: 21792211
    [Abstract] [Full Text] [Related]

  • 27. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
    Srinivasu P, Subbarao DV, Vegesna RV, Sudhakar Babu K.
    J Pharm Biomed Anal; 2010 May 01; 52(1):142-8. PubMed ID: 20053517
    [Abstract] [Full Text] [Related]

  • 28. Identification and characterization of potential impurities of amlodipine maleate.
    Sudhakar P, Nirmala M, Moses Babu J, Vyas K, Madhusudan Reddy G, Vijaya Bhaskar B, Pratap Reddy P, Mukkanti K.
    J Pharm Biomed Anal; 2006 Feb 24; 40(3):605-13. PubMed ID: 16324814
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Isolation and characterization of degradation products of citalopram and process-related impurities using RP-HPLC.
    Rao RN, Raju AN, Narsimha R.
    J Sep Sci; 2008 Jun 24; 31(10):1729-38. PubMed ID: 18481321
    [Abstract] [Full Text] [Related]

  • 36. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M, Siva Kumari K, Pratap Reddy P, Naidu MN, Moses Babu J, Srivastava AK, Lakshmi Kumar T, Chandra Sekhar BV, Satyanarayana B.
    J Pharm Biomed Anal; 2008 Nov 04; 48(3):708-15. PubMed ID: 18755563
    [Abstract] [Full Text] [Related]

  • 37. Gradient RP-HPLC method for the determination of potential impurities in atazanavir sulfate.
    Chitturi SR, Somannavar YS, Peruri BG, Nallapati S, Sharma HK, Budidet SR, Handa VK, Vurimindi HB.
    J Pharm Biomed Anal; 2011 Apr 28; 55(1):31-47. PubMed ID: 21316175
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of a novel process-related impurity in commercial bendazac lysine eye drops by LC-ESI-QTOF/MS/MS and NMR.
    Zhu P, Yang W, Hong L, Cheng Q, Luo L, He J, Chen J.
    J Pharm Biomed Anal; 2015 Mar 25; 107():437-43. PubMed ID: 25666544
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.